scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.CLD.2010.07.003 |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S108932611000067X?httpAccept=text/plain |
https://api.elsevier.com/content/article/PII:S108932611000067X?httpAccept=text/xml | ||
P698 | PubMed publication ID | 21055683 |
P2093 | author name string | Maha Guindi | |
P2860 | cites work | Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis | Q28289028 |
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis | Q33784003 | ||
Epitope spreading in immune-mediated diseases: implications for immunotherapy | Q34575350 | ||
Autoimmune liver disease: overlap and outliers | Q34626237 | ||
The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants | Q34936648 | ||
Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis | Q35597275 | ||
T cell immunity in autoimmune hepatitis | Q36180095 | ||
Antigen processing by autoreactive B cells promotes determinant spreading | Q36280504 | ||
Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis | Q36705632 | ||
Chronic HCV-related autoimmunity: a consequence of viral persistence and lymphotropism | Q36754521 | ||
The variant forms of autoimmune hepatitis | Q36820820 | ||
Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging | Q37058826 | ||
Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome | Q37091952 | ||
Postinfantile giant-cell transformation in hepatitis | Q42061603 | ||
Plasma cell hepatitis in liver allografts: Variant of rejection or autoimmune hepatitis? | Q42978721 | ||
Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes | Q43048266 | ||
Use of corticosteroid therapy in autoimmune hepatitis resulting in the resolution of cirrhosis | Q43586384 | ||
Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy | Q43586395 | ||
Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients | Q43903202 | ||
Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis | Q43948285 | ||
Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal | Q44002045 | ||
Diagnosis and treatment of autoimmune hepatitis | Q44080061 | ||
Simplified criteria for the diagnosis of autoimmune hepatitis | Q44425899 | ||
Histological findings in chronic hepatitis C with autoimmune features | Q45162387 | ||
The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis | Q46858579 | ||
Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis? | Q50897195 | ||
Present status of autoimmune hepatitis in Japan--correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. | Q50948422 | ||
The nature and prognosis of severe cryptogenic chronic active hepatitis. | Q51052985 | ||
Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis. | Q51865630 | ||
Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. | Q52847864 | ||
Autoimmune hepatitis with incidental histologic features of bile duct injury. | Q53321597 | ||
Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis. An Italian experience. | Q53371048 | ||
Development of autoimmune hepatitis in primary biliary cirrhosis. | Q53713488 | ||
Autoimmune Hepatitis | Q56210456 | ||
Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis | Q57004434 | ||
Viral and autoimmune hepatitis. Morphologic and pathogenetic aspects of cell damage in hepatitis with potential chronicity | Q69304093 | ||
Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis | Q69662304 | ||
Meeting report: International Autoimmune Hepatitis Group | Q70496892 | ||
Validation of scoring system for diagnosis of autoimmune hepatitis | Q71000931 | ||
Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis | Q71039699 | ||
Corticosteroid-treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitis | Q71373108 | ||
Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis | Q71428816 | ||
Azathioprine for Long-Term Maintenance of Remission in Autoimmune Hepatitis | Q72039839 | ||
Recent-onset autoimmune hepatitis. Biopsy findings and clinical correlations | Q72248910 | ||
The nature and prognostic implications of autoimmune hepatitis with an acute presentation | Q72631955 | ||
Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis | Q72638615 | ||
A novel histological lesion in glucocorticoid-responsive chronic hepatitis | Q73565393 | ||
Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study | Q73568156 | ||
Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis | Q79798205 | ||
Effect of treatment of hepatic histopathology in children and adolescents with autoimmune hepatitis | Q80418315 | ||
Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation | Q80545740 | ||
The challenge of diagnosing autoimmune hepatitis: less is more | Q81503312 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | autoimmune hepatitis | Q786844 |
P304 | page(s) | 577-590 | |
P577 | publication date | 2010-11-01 | |
P1433 | published in | Clinics in liver disease | Q26842322 |
P1476 | title | Histology of autoimmune hepatitis and its variants | |
Histology of Autoimmune Hepatitis and its Variants | |||
P478 | volume | 14 |
Q59349440 | Autoimmune hepatitis |
Q86886381 | Autoimmune hepatitis |
Q28087726 | Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics |
Q39413444 | Challenges and difficulties in pathological diagnosis of autoimmune hepatitis |
Q99613002 | Circular RNAs associated with a mouse model of concanavalin A-induced autoimmune hepatitis: Preliminary screening and comprehensive functional analysis |
Q37969669 | Diagnosis and treatment of autoimmune hepatitis |
Q36346954 | Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury. |
Q38238921 | Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis |
Q41183157 | Histological Changes in Autoimmune Hepatitis with Graves' Disease: A Child Case Report |
Q34369116 | Review article: autoimmune hepatitis -- current management and challenges. |
Q59130562 | The Geoepidemiology of Autoimmune Liver Disease |
Q38037392 | The overlap syndromes of autoimmune hepatitis |